The U.S. must take urgent steps to rein in the out-of-control cost of prescription drugs, including aggressive government intervention to negotiate lower prices for American patients, a panel of the National Academies of Sciences, Engineering, and Medicine recommended Thursday in a sweeping new report on pharmaceutical pricing.
The report — titled “Making Medicines Affordable: A National Imperative” — includes a strongly worded indictment of the nation’s prescription drug market, which it warns is failing millions of sick patients.
Read Next
